Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Other News Releases in OTC, SmallCap

GuestTek International, Inc. to Issue Shot Spirits Stock Dividend to Shareholders of Record as of January 15, 2010

Mestek, Inc. Announces Final Results of Tender Offer

Blue Gem Enterprise To Distribute Apple Rush Organic Juices

Other News Releases in Contracts

Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications

Tsingtao Beer and QSL Join Hands to Promote Youth Sports

International Association of Machinists at Alaska Airlines Approve One Contract Extension, Reject Another

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

See more news releases in: OTC, SmallCap, Health Care & Hospitals, Medical Pharmaceuticals, Contracts

 

China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009

HAIKOU CITY, China, Oct. 28 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release third quarter 2009 financial results on Thursday, November 12, 2009, before the market opens.

The Company will hold a conference call at 8:00 am ET on November 12, 2009 to discuss fiscal third quarter 2009 results. Listeners may access the call by dialing 1-866-271-6130 or 1-617-213-8894 for international callers, access code: 14971758. A webcast will also be available through CPHI's website at http://www.chinapharmaholdings.com . A replay of the call will be accessible through November 19, 2009 by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 89842045.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .

    For more information, please contact:

     China Pharma Holdings, Inc.
     Tel:   +86-898-6681-1730
     Email: hps@chinapharmaholdings.com

     ICR, Inc.
     Christine Duan
     Tel:   +1-203-682-8200

SOURCE China Pharma Holdings, Inc.